Compare AA & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AA | BAX |
|---|---|---|
| Founded | 1888 | 1931 |
| Country | United States | United States |
| Employees | N/A | 37500 |
| Industry | Aluminum | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 13.4B |
| IPO Year | 2016 | 1994 |
| Metric | AA | BAX |
|---|---|---|
| Price | $39.73 | $25.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 15 |
| Target Price | ★ $54.59 | $27.25 |
| AVG Volume (30 Days) | 4.1M | ★ 7.1M |
| Earning Date | 10-15-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.99% | 0.16% |
| EPS Growth | ★ 1580.77 | N/A |
| EPS | ★ 4.95 | 0.78 |
| Revenue | ★ $12,831,000,000.00 | $11,244,000,000.00 |
| Revenue This Year | $14.30 | $4.27 |
| Revenue Next Year | $1.35 | $2.01 |
| P/E Ratio | ★ $8.18 | $33.10 |
| Revenue Growth | ★ 7.87 | 5.72 |
| 52 Week Low | $35.12 | $15.73 |
| 52 Week High | $84.38 | $30.00 |
| Indicator | AA | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 54.55 |
| Support Level | $37.95 | $25.75 |
| Resistance Level | $44.28 | $26.54 |
| Average True Range (ATR) | 1.39 | 1.16 |
| MACD | 0.28 | 0.09 |
| Stochastic Oscillator | 38.96 | 72.11 |
Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is one of the world's largest bauxite miners and alumina refiners by production volume, but sits outside the top-10 aluminum producers, a list dominated by Chinese companies. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.